IMiD compounds affect CD34+ cell fate and maturation via CRBN-induced IKZF1 degradation

Autor: Li, Shirong *, Fu, Jing *, Wang, Hui, Ma, Huihui, Xu, Xiaoming, Yang, Yong-Guang, Deng, Shixian, Mapara, Markus Y., Lentzsch, Suzanne
Zdroj: In Blood Advances 13 March 2018 2(5):492-504
Databáze: ScienceDirect